Alerts
Other content recommended for you
- The COVID-19 vaccine patent: a right without rationale
- Pregabalin: what the patent litigation means for doctors and drug companies
- “World’s pharmacy” faces new challenges from Western drug companies
- Novartis challenges India’s drug patent laws in Supreme Court
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- The impact of intellectual property regulation on global medical technology innovation
- Patent wars: affordable medicines versus intellectual property rights
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- Healing an ailing pharmaceutical system: prescription for reform for United States and Canada
- Global equitable access to vaccines, medicines and diagnostics for COVID-19: The role of patents as private governance